Article Details
Retrieved on: 2018-01-19 23:23:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Fic <b>Capital</b> Inc decreased its stake in Alnylam Pharma (ALNY) by 11.54% based on its latest 2017Q3 regulatory filing with the SEC. Fic <b>Capital</b> Inc sold 19,653 shares as the company's stock rose 48.45% with the market. The institutional investor held 150,676 shares of the health care company at the end ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here